DB

Diebold Nixdorf, Incorporated

DBDTechnologyNASDAQ

Software - Application · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.81B
+1.5% YoY
Net Income
$94.6M
+673.3% YoY
EBITDA
$338.3M
+1.0% YoY
Free Cash Flow
$324.5M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 8 MACD Negative CrossoverHistogram -0.1182, negative momentum
Jul 7 MACD Negative CrossoverHistogram -0.0682, negative momentum
About Diebold Nixdorf, Incorporated

Headquartered within the technology sector, Diebold Nixdorf, Incorporated focuses on Software - Application services and products. Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. At a $2.97B market cap, Diebold Nixdorf, Incorporated ranks as a mid-cap company within technology. It operates through two segments, Banking and Retail.

Key stats
Market Cap$2.97B
P/E (TTM)29.44
Fwd P/E12.61
EPS$2.91
Beta1.11
52W Change+45.2%
ROE11.0%
Analysis

The company holds $358.6M in cash, though total debt stands at $1.09B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $324.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 11.0%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.8% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $3.91B (2021) to $3.81B (2025).

As with any equity investment, DBD carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing DBD's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Technology stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms